Ludivine Beaussire Selected Research

Ludivine Beaussire Research Topics

9	Neoplasms (Cancer) 01/2022 - 10/2015
6	Breast Neoplasms (Breast Cancer) 11/2023 - 11/2016
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2015
2	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 11/2023
1	Carcinogenesis 04/2023
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Disease Progression 01/2022
1	Gliosarcoma 11/2020
1	Ependymoma 10/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Adenocarcinoma 09/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016

7	Cell-Free Nucleic AcidsIBA 01/2022 - 10/2015
4	Hormones (Hormone)IBA 11/2023 - 11/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2015
3	Aromatase InhibitorsIBA 11/2023 - 11/2016
2	Circulating Tumor DNAIBA 11/2023 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 11/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2017
1	Megestrol Acetate (Borea)FDA LinkGeneric 11/2023
1	Circular RNAIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Fetal Proteins (Fetoprotein)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	ParaffinIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	TropomyosinIBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 11/2020
1	epidermal growth factor receptor VIIIIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Aromatase (CYP19)IBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Edetic Acid (EDTA)FDA Link 09/2017
1	IceIBA 02/2017